Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma

Journal of Investigative Dermatology

Volumn 122, Issue 3, 2004, Pages 594-601

  Nagai, Masaki ^a   Hasegawa, Minoru ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Fibrosis; Reactive oxygen species

Indexed keywords

AUTOANTIBODY; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MORPHEA; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCLERODERMA; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 1842690035     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22333.x     Document Type: Article

References (40)

1. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-348, 1975a
2. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-407, 1975b
3. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA: Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J Biol Chem 264:16957-16962, 1989
4. Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M: Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: Clinical trial. Radiother Oncol 32:12-20, 1994
5. Delanian S, Martin M, Bravard A, Luccioni C, Lefaix JL: Cu/Zn superoxide dismutase modulates phenotypic changes in cultured fibroblasts from human skin with chronic radiotherapy damage. Radiother Oncol 58:325-331, 2001
6. Falanga V, Medsger TA Jr, Reichlin M: Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123:350-353, 1987
7. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP: Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104:849-857, 1986
8. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122, 1997
9. Gurney ME, Pu H, Chiu AY, et al: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775, 1994
10. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C: Immunocytochemical localization and serologic detection of transforming growth factor β1: Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278-288, 1994
11. Jablonska S, Rodnan GP: Localized forms of scleroderma. Clin Rheum Dis 5:215-241, 1979
12. Komocsi A, Tovari E, Kovacs J, Czirjak L: Physical injury as a provoking factor in three patients with scleroderma. Clin Exp Rheumatol 18:622-624, 2000
13. Kubo M, Ihn H, Yamane K, Tamaki K: Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 44:731-734, 2001
14. Lefaix JL, Delanian S, Leplat JJ, et al: Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study. Int J Radiat Oncol Biol Phys 35:305-312, 1996
15. LeRoy EC, Krieg T, Black C, et al: Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 15:202-205, 1988
16. Marklund SL: Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222:649-655, 1964
17. Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, Kahari VM: Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 110:416-421, 1998
18. Miyata M, Kogure A, Sato H, et al: Detection of antibodies to 65 KD heat shock protein and to human superoxide dismutase in autoimmune hepatitis-molecular mimicry between 65 KD heat shock protein and superoxide dismutase. Clin Rheumatol 14:673-677, 1995
19. Noor R, Mittal S, Iqbal J: Superoxide dismutase - Applications and relevance to human diseases. Med Sci Monit 8:RA210-215, 2002
20. Okano Y: Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22:709-735, 1996
21. Reaume AG, Elliott JL, Hoffman EK, et al: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47, 1996
22. Ritter K, Kuhl RJ, Semrau F, Eiffert H, Kratzin HD, Thomssen R: Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection. J Exp Med 180:1995-1998, 1994
23. Rosen DR, Siddique T, Patterson D, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62, 1993
24. Ruiz IG, de la Torre P, Diaz T, Esteban E, Morillas JD, Munoz-Yague T, Solis-Herruzo JA: Sp family of transcription factors is involved in iron-induced collagen α1(I) gene expression. DNA Cell Biol 19:167-178, 2000
25. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A: Oxidative stress in scleroderma: Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulatlon of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44:2653-2664, 2001
26. Sato S, Fujimoto M, Hasegawa M, Takehara K: Anti-phospholipid antibody in localized scleroderma. Ann Rheum Dis 62:771-774, 2003
27. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K: Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 130:1273-1277, 1994a
28. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K: Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:567-571, 1994b
29. Sato S, Ihn H, Soma Y, et al: Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137-1141, 1993
30. Semrau F, Kuhl RJ, Ritter S, Ritter K: Manganese superoxide dismutase (MnSOD) and autoantibodies against MnSOD in acute viral infections. J Med Virol 55:161-167, 1998
31. Speer CP, Pabst MJ, Hedegaard HB, Rest RF, Johnston RB Jr: Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: Activity of neutrophil elastase and cathepsin G. J Immunol 133:2151-2156, 1984
32. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
33. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
34. Trattner A, Figer A, David M, Lurie H, Sandbank M: Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 68:2131-2133, 1991
35. Varga J: Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 46:1703-1713, 2002
36. Vozenin-Brotons MC, Sivan V, Gault N, et al: Antifibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med 30:30-42, 2001
37. Yamamolo T, Takagawa S, Katayama I, Mizushima Y, Nishioka K: Effect of superoxide dismutase on bleomycin-induced dermal sclerosis: Implications for the treatment of systemic sclerosis. J Invest Dermatol 113:843-847, 1999
38. Yamazaki C, Hoshino J, Hori Y, Sekiguchi T, Miyauchi S, Mizuno S, Horie K: Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice. Jpn J Pharmacol 75:97-100, 1997
39. Zelko IN, Mariani TJ, Folz RJ: Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337-349, 2002
40. Zhong Z, Froh M, Wheeler MD, Smutney O, Lehmann TG, Thurman RG: Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat. Gene Ther 9:183-191, 2002